These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Improvement in neurological outcome and abolition of cerebrovascular endothelin B and 5-hydroxytryptamine 1B receptor upregulation through mitogen-activated protein kinase kinase 1/2 inhibition after subarachnoid hemorrhage in rats. Larsen CC, Povlsen GK, Rasmussen MN, Edvinsson L. J Neurosurg; 2011 Apr; 114(4):1143-53. PubMed ID: 20597604 [Abstract] [Full Text] [Related]
3. ERK1/2 inhibition attenuates cerebral blood flow reduction and abolishes ET(B) and 5-HT(1B) receptor upregulation after subarachnoid hemorrhage in rat. Beg SA, Hansen-Schwartz JA, Vikman PJ, Xu CB, Edvinsson LI. J Cereb Blood Flow Metab; 2006 Jun; 26(6):846-56. PubMed ID: 16251886 [Abstract] [Full Text] [Related]
4. Protein kinase C inhibition prevents upregulation of vascular ET(B) and 5-HT(1B) receptors and reverses cerebral blood flow reduction after subarachnoid haemorrhage in rats. Beg SS, Hansen-Schwartz JA, Vikman PJ, Xu CB, Edvinsson LI. J Cereb Blood Flow Metab; 2007 Jan; 27(1):21-32. PubMed ID: 16736053 [Abstract] [Full Text] [Related]
5. Equal contribution of increased intracranial pressure and subarachnoid blood to cerebral blood flow reduction and receptor upregulation after subarachnoid hemorrhage. Laboratory investigation. Ansar S, Edvinsson L. J Neurosurg; 2009 Nov; 111(5):978-87. PubMed ID: 19408972 [Abstract] [Full Text] [Related]
6. Involvement of calcium-calmodulin-dependent protein kinase II in endothelin receptor expression in rat cerebral arteries. Waldsee R, Ahnstedt H, Eftekhari S, Edvinsson L. Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H823-32. PubMed ID: 20008273 [Abstract] [Full Text] [Related]
9. Neurokinin-1 receptor antagonism in a rat model of subarachnoid hemorrhage: prevention of upregulation of contractile ETB and 5-HT1B receptors and cerebral blood flow reduction. Ansar S, Svendgaard NA, Edvinsson L. J Neurosurg; 2007 May; 106(5):881-6. PubMed ID: 17542534 [Abstract] [Full Text] [Related]
13. Clazosentan, an endothelin receptor antagonist, prevents early hypoperfusion during the acute phase of massive experimental subarachnoid hemorrhage: a laser Doppler flowmetry study in rats. Schubert GA, Schilling L, Thomé C. J Neurosurg; 2008 Dec; 109(6):1134-40. PubMed ID: 19035733 [Abstract] [Full Text] [Related]
18. Vascular pathology of large cerebral arteries in experimental subarachnoid hemorrhage: Vasoconstriction, functional CGRP depletion and maintained CGRP sensitivity. Johansson SE, Abdolalizadeh B, Sheykhzade M, Edvinsson L, Sams A. Eur J Pharmacol; 2019 Mar 05; 846():109-118. PubMed ID: 30653947 [Abstract] [Full Text] [Related]